A detailed history of Wolverine Asset Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wolverine Asset Management LLC holds 949 shares of APLS stock, worth $31,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
949
Holding current value
$31,620
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$28.84 - $41.15 $27,369 - $39,051
949 New
949 $27,000
Q3 2023

Nov 13, 2023

BUY
$23.65 - $89.22 $144,265 - $544,242
6,100 New
6,100 $232,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.66B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.